BioLab Holdings, Inc., announced the initiation of the BIOCAMP study assessing the company’s human placental membrane (HPM ...

Merit Medical Systems, Inc. recently announced the United States commercial release of the Prelude Wave hydrophilic sheath intro ...

Instylla, Inc. announced premarket approval (PMA) from the FDA for the company’s flagship Embrace hydrogel embolic system.

Royal Philips recently announced FDA 510(k) clearance of the latest version of the company’s UroNav system for image-guided ...

The Society of Interventional Oncology (SIO) recently announced the completion of enrollment for its clinical trial, ...

Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, announced ...

Inari Medical, now part of Stryker, announced the launch of its next-generation InThrill thrombectomy system. According to ...

HistoSonics, the developer of the Edison histotripsy system and histotripsy therapy platform, announced a management-led majority ...

Vexev and U.S. Renal Care announced the completion of enrollment in the CANSCAN clinical trial, a multicenter feasibility s ...